Milner Seminar: Focus on Neurodegeneration

An in-person seminar at the Milner Therapeutics Institute in Cambridge, with two talks on neurodegeneration from disease mechanisms through to new treatments, followed by an hour of networking.

The Milner Seminar series brings together speakers from academia and industry. This session focuses on neurodegeneration: how inflammation in the brain and the body can be measured and tracked into clinical trials, and how universities and industry can work together to get treatments developed. It’s held in person to encourage informal discussion, so it’s a good chance to meet people working across the Cambridge neurodegeneration and drug discovery community.

When

Wednesday 18th November – 16:00 to 18:00

Where

Lecture Theatre, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge CB2 0AW

Programme

• 16:00 – Dr Maura Malpetti (Department of Clinical Neurosciences, University of Cambridge): fingerprinting brain and peripheral inflammation in neurodegeneration, from discovery to trials
• 16:30 – John Skidmore (ALBORADA Drug Discovery Institute, University of Cambridge): building bridges between academia and industry to develop treatments for neurodegenerative diseases
• 17:00 – Networking and refreshments
• 18:00 – Close

Related reading

For more on the themes of the talks, read about the role of inflammation in Alzheimer’s disease, or hear Fiona Ducotterd on a career in dementia drug discovery.

Organiser

Organised by the Milner Therapeutics Institute, University of Cambridge. Questions go to events@milner.cam.ac.uk.

Register